ISSN: 2578-4803
Authors: Desai S*
Voriconazole API (active pharmaceutical ingredient) a thermolabile antifungal drug developed in 1980’s -a triazole class of drugs successfully surpassed the antifungal drugs having huge demand in market sales globally for its applications to treat severe fungal/yeast infections. The market growth involves its evolution of product in terms of innovation & technologies to withstand the competitiveness in aspect of new entry of drug, suppliers and buyers. The voriconazole drug surpassed USD 10 million dollars in 2023 within three years starting in the year 2020. the market report analysis collected from the various published news articles and the research publications from various business market reports of the manufactured industry reports. In this article we focus on the formulation strategies and research studies that made voriconazole drug stand in the market aiming futuristic growth.
Keywords: Voriconazole; Market Growth; Formulation Strategy; Innovation
